MFDS
- Marketing authorisation holder: ASTELLAS
- Status: likely_approved
🇰🇷 Vyloy in South Korea
Vyloy (ZOLBETUXIMAB) regulatory status in South Korea.
Marketing authorisation
Vyloy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Vyloy approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Vyloy in South Korea?
ASTELLAS holds the South Korean marketing authorisation.